Delivery Order SPE2DR25D7055-SPE2DR26FV5UN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,217.11 to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion date of January 27, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal healthcare systems. This...
- The Defense Logistics Agency (DLA) awarded a $6,617.22 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion date of December 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,102.87 by the Defense Logistics Agency (DLA) on January 8, 2026, for Shingrix vial kits with an ultimate completion date of January 9, 2026. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award through open competition. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 8, 2026, for Shingrix vial kits with a ceiling value of $1,198.97. This is a firm fixed-price delivery order with an ultimate completion date of January 9, 2026, and does not utilize a set-aside designation. The award was made through open competition, consistent with Amerisourcebergen's established track record as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,278.36 to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion date of September 8, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor will perform...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,260.14 to AmerisourceBergen Drug Corp for Shingrix vial kits on November 5, 2025, with an ultimate completion date of November 6, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order valued at $23,047.01 to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion date of November 13, 2025. This competitive award uses firm fixed-price pricing and represents a non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The place...
- The Defense Logistics Agency awarded a delivery order valued at $8,655.43 to AmerisourceBergen Drug Corp for Shingrix vial kits on November 6, 2025, with an ultimate completion date of November 7, 2025. This firm fixed-price contract, which is not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $15,660.99 to AmerisourceBergen Drug Corp for Shingrix vial kits. The contract is firm fixed price with no set-aside designation and has an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and holds the place of performance for this award at its corporate office location. This...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, to provide 4,563,679,629 units of SHINGRIX vial kits. The order, valued at $3,312.24, has a completion date of February 16, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this delivery order. This award is not associated with a...
- SPE2DR25D7055Indefinite Delivery Contract
- SPE2DR25D7055-SPE2DR26FV5UNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,397.94 to Amerisourcebergen Drug Corp for Shingrix vial kits, with an ultimate completion date of February 2, 2026. This is a firm fixed-price contract with no set-aside designation, indicating competitive award. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company performs this work from its corporate office location in Conshohocken, PA. This delivery order is issued under Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This comprehensive global pharmaceutical support vehicle enables the delivery of a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The Shingrix order supports the DLA's pharmaceutical supply chain for military treatment facilities and federal healthcare systems requiring this recombinant zoster vaccine.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/29/26 |